1. Home
  2. BELFA vs LQDA Comparison

BELFA vs LQDA Comparison

Compare BELFA & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BELFA
  • LQDA
  • Stock Information
  • Founded
  • BELFA 1949
  • LQDA 2004
  • Country
  • BELFA United States
  • LQDA United States
  • Employees
  • BELFA N/A
  • LQDA N/A
  • Industry
  • BELFA
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BELFA
  • LQDA Health Care
  • Exchange
  • BELFA Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • BELFA 1.1B
  • LQDA 929.0M
  • IPO Year
  • BELFA N/A
  • LQDA 2018
  • Fundamental
  • Price
  • BELFA $91.60
  • LQDA $9.84
  • Analyst Decision
  • BELFA
  • LQDA Strong Buy
  • Analyst Count
  • BELFA 0
  • LQDA 8
  • Target Price
  • BELFA N/A
  • LQDA $27.14
  • AVG Volume (30 Days)
  • BELFA 13.1K
  • LQDA 751.9K
  • Earning Date
  • BELFA 10-23-2024
  • LQDA 11-13-2024
  • Dividend Yield
  • BELFA 0.26%
  • LQDA N/A
  • EPS Growth
  • BELFA N/A
  • LQDA N/A
  • EPS
  • BELFA 4.32
  • LQDA N/A
  • Revenue
  • BELFA $524,943,000.00
  • LQDA $15,610,000.00
  • Revenue This Year
  • BELFA N/A
  • LQDA N/A
  • Revenue Next Year
  • BELFA $3.23
  • LQDA $227.73
  • P/E Ratio
  • BELFA $21.18
  • LQDA N/A
  • Revenue Growth
  • BELFA N/A
  • LQDA N/A
  • 52 Week Low
  • BELFA $51.00
  • LQDA $6.19
  • 52 Week High
  • BELFA $106.93
  • LQDA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • BELFA 31.21
  • LQDA 33.81
  • Support Level
  • BELFA $97.00
  • LQDA $10.17
  • Resistance Level
  • BELFA $104.73
  • LQDA $10.95
  • Average True Range (ATR)
  • BELFA 2.66
  • LQDA 0.39
  • MACD
  • BELFA -1.34
  • LQDA -0.13
  • Stochastic Oscillator
  • BELFA 3.77
  • LQDA 3.79

About BELFA Bel Fuse Inc.

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: